Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
The latest announcement is out from Femasys ( (FEMY) ).
On November 6, 2025, Femasys Inc. announced a significant initial order valued at approximately $500,000 USD for the commercial launch of FemBloc Permanent Birth Control in France and the Benelux region through its partnership with Kebomed. This order marks continued progress in expanding FemBloc’s presence across key European markets, reflecting growing international momentum for this innovative, non-surgical permanent contraceptive solution. FemBloc, a first-of-its-kind non-surgical solution for permanent birth control, addresses a significant unmet need in women’s reproductive health by providing a safer, more convenient, and affordable option compared to surgical sterilization.
The most recent analyst rating on (FEMY) stock is a Hold with a $1.00 price target. To see the full list of analyst forecasts on Femasys stock, see the FEMY Stock Forecast page.
Spark’s Take on FEMY Stock
According to Spark, TipRanks’ AI Analyst, FEMY is a Neutral.
Femasys faces significant financial challenges with persistent losses and cash flow issues, heavily impacting its overall score. Technical indicators show some short-term bullish momentum, but the negative P/E ratio and lack of dividend yield weigh negatively on valuation. The absence of earnings call and corporate events data limits further insights.
To see Spark’s full report on FEMY stock, click here.
More about Femasys
Femasys Inc. is a leading biomedical innovator focused on making fertility and non-surgical permanent birth control more accessible and cost-effective for women worldwide. The company offers a broad, patent-protected portfolio of novel, in-office therapeutic and diagnostic products, including FemaSeed Intratubal Insemination and FemVue, a diagnostic for fallopian tube assessment. Femasys is actively commercializing its lead product innovations in the U.S. and key international markets.
Average Trading Volume: 7,842,278
Technical Sentiment Signal: Sell
Current Market Cap: $44.73M
Learn more about FEMY stock on TipRanks’ Stock Analysis page.